OBJECTIVE: To identify trajectories of depressive symptoms in older community residents. METHOD: Depressive symptomatology, based on a modified Center for Epidemiological Studies-Depression scale, was obtained at years 0, 3, 6, and 10, in the Duke Established Populations for Epidemiologic Studies of the Elderly (n = 4162). Generalized growth mixture models identified the latent class trajectories present. Baseline demographic, health, and social characteristics distinguishing the classes were identified using multinomial logistic regression. RESULTS: Four latent class trajectories were identified. Class 1 - stable low depressive symptomatology (76.6% of the sample); class 2 - initially low depressive symptomatology, increasing to the subsyndromal level (10.0%); class 3 - stable high depressive symptomatology (5.4%); class 4 - high depressive symptomatology improving over 6 years before reverting somewhat (8.0%). Class 1 was younger, male gender, with better education, health, and social resources, in contrast to class 3. Class 2 had poorer cognitive functioning and higher death rate. Class 4 had better health and social resources. CONCLUSION: Reduction in high depressive symptomatology is associated with more education, better health, fewer stressful events, and a larger social network. Increasing depressive symptomatology is accompanied by poorer physical and cognitive health, more stressful life events, and greater risk of death.
OBJECTIVE: To identify trajectories of depressive symptoms in older community residents. METHOD:Depressive symptomatology, based on a modified Center for Epidemiological Studies-Depression scale, was obtained at years 0, 3, 6, and 10, in the Duke Established Populations for Epidemiologic Studies of the Elderly (n = 4162). Generalized growth mixture models identified the latent class trajectories present. Baseline demographic, health, and social characteristics distinguishing the classes were identified using multinomial logistic regression. RESULTS: Four latent class trajectories were identified. Class 1 - stable low depressive symptomatology (76.6% of the sample); class 2 - initially low depressive symptomatology, increasing to the subsyndromal level (10.0%); class 3 - stable high depressive symptomatology (5.4%); class 4 - high depressive symptomatology improving over 6 years before reverting somewhat (8.0%). Class 1 was younger, male gender, with better education, health, and social resources, in contrast to class 3. Class 2 had poorer cognitive functioning and higher death rate. Class 4 had better health and social resources. CONCLUSION: Reduction in high depressive symptomatology is associated with more education, better health, fewer stressful events, and a larger social network. Increasing depressive symptomatology is accompanied by poorer physical and cognitive health, more stressful life events, and greater risk of death.
Authors: S Jay Olshansky; Douglas J Passaro; Ronald C Hershow; Jennifer Layden; Bruce A Carnes; Jacob Brody; Leonard Hayflick; Robert N Butler; David B Allison; David S Ludwig Journal: N Engl J Med Date: 2005-03-17 Impact factor: 91.245
Authors: Gregory E Simon; Wayne J Katon; Elizabeth H B Lin; Carolyn Rutter; Willard G Manning; Michael Von Korff; Paul Ciechanowski; Evette J Ludman; Bessie A Young Journal: Arch Gen Psychiatry Date: 2007-01
Authors: N Amin; O Jovanova; H H H Adams; A Dehghan; M Kavousi; M W Vernooij; R P Peeters; F M S de Vrij; S J van der Lee; J G J van Rooij; E M van Leeuwen; L Chaker; A Demirkan; A Hofman; R W W Brouwer; R Kraaij; K Willems van Dijk; T Hankemeier; W F J van Ijcken; A G Uitterlinden; W J Niessen; O H Franco; S A Kushner; M A Ikram; H Tiemeier; C M van Duijn Journal: Mol Psychiatry Date: 2016-07-19 Impact factor: 15.992
Authors: Joyce T Bromberger; Laura L Schott; Nancy E Avis; Sybil L Crawford; Sioban D Harlow; Hadine Joffe; Howard M Kravitz; Karen A Matthews Journal: Psychol Med Date: 2018-04-06 Impact factor: 7.723
Authors: Allison R Kaup; Amy L Byers; Cherie Falvey; Eleanor M Simonsick; Suzanne Satterfield; Hilsa N Ayonayon; Stephen F Smagula; Susan M Rubin; Kristine Yaffe Journal: JAMA Psychiatry Date: 2016-05-01 Impact factor: 21.596
Authors: Karin Hek; Ayse Demirkan; Jari Lahti; Antonio Terracciano; Alexander Teumer; Cornelia M van Duijn; Hans J Grabe; Lenore J Launer; Kathryn L Lunetta; Thomas H Mosley; Anne B Newman; Henning Tiemeier; Joanne Murabito; Marilyn C Cornelis; Najaf Amin; Erin Bakshis; Jens Baumert; Jingzhong Ding; Yongmei Liu; Kristin Marciante; Osorio Meirelles; Michael A Nalls; Yan V Sun; Nicole Vogelzangs; Lei Yu; Stefania Bandinelli; Emelia J Benjamin; David A Bennett; Dorret Boomsma; Alessandra Cannas; Laura H Coker; Eco de Geus; Philip L De Jager; Ana V Diez-Roux; Shaun Purcell; Frank B Hu; Eric B Rimma; David J Hunter; Majken K Jensen; Gary Curhan; Kenneth Rice; Alan D Penman; Jerome I Rotter; Nona Sotoodehnia; Rebecca Emeny; Johan G Eriksson; Denis A Evans; Luigi Ferrucci; Myriam Fornage; Vilmundur Gudnason; Albert Hofman; Thomas Illig; Sharon Kardia; Margaret Kelly-Hayes; Karestan Koenen; Peter Kraft; Maris Kuningas; Joseph M Massaro; David Melzer; Antonella Mulas; Cornelis L Mulder; Anna Murray; Ben A Oostra; Aarno Palotie; Brenda Penninx; Astrid Petersmann; Luke C Pilling; Bruce Psaty; Rajesh Rawal; Eric M Reiman; Andrea Schulz; Joshua M Shulman; Andrew B Singleton; Albert V Smith; Angelina R Sutin; André G Uitterlinden; Henry Völzke; Elisabeth Widen; Kristine Yaffe; Alan B Zonderman; Francesco Cucca; Tamara Harris; Karl-Heinz Ladwig; David J Llewellyn; Katri Räikkönen; Toshiko Tanaka Journal: Biol Psychiatry Date: 2013-01-03 Impact factor: 13.382
Authors: Megan M Marron; Stewart J Anderson; Jessica Garrity; Charles F Reynolds; Francis E Lotrich Journal: Psychosom Med Date: 2015-10 Impact factor: 4.312
Authors: Julia B Ward; Whitney R Robinson; Brian W Pence; Joanna Maselko; Sandra S Albrecht; Mary N Haan; Allison E Aiello Journal: Am J Epidemiol Date: 2018-08-01 Impact factor: 4.897
Authors: Katherine L Musliner; Trine Munk-Olsen; Thomas M Laursen; William W Eaton; Peter P Zandi; Preben B Mortensen Journal: JAMA Psychiatry Date: 2016-04 Impact factor: 21.596